GOBBI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 70
EU - Europa 53
AS - Asia 14
AF - Africa 6
Totale 143
Nazione #
US - Stati Uniti d'America 70
DE - Germania 15
GB - Regno Unito 12
IT - Italia 11
IN - India 9
SE - Svezia 6
IE - Irlanda 5
TG - Togo 5
CN - Cina 3
BG - Bulgaria 2
JO - Giordania 2
FR - Francia 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 143
Città #
Southend 11
Princeton 8
Ashburn 7
Bologna 6
Chandler 5
Dublin 5
Fairfield 5
Houston 5
Lomé 5
Berlin 3
Redmond 3
Amman 2
Ann Arbor 2
Bühl 2
Chicago 2
Des Moines 2
Forlì 2
Leawood 2
Olalla 2
Sofia 2
Cambridge 1
Hebei 1
Jinan 1
Seattle 1
Westminster 1
Wilmington 1
Woodbridge 1
Totale 88
Nome #
The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells 49
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma 40
Csnk1a1, kdm2a, and ltb4r2 are new druggable vulnerabilities in lung cancer 34
Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy 32
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling 7
Totale 162
Categoria #
all - tutte 923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 923


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 3 1 1 1 0
2020/202119 2 1 1 1 1 0 0 5 4 0 0 4
2021/202249 1 0 4 0 4 2 0 10 12 1 9 6
2022/202362 4 8 4 4 2 12 5 6 10 2 0 5
2023/202426 2 2 2 3 1 3 0 1 2 1 9 0
Totale 162